[1] |
Zheng Rui, Zhao Mingrui, Yang Yuanzheng.
Meta-analysis of effectiveness and safety of the cycloserine-containing treatment for multidrug-resistant pulmonary tuberculosis in China
[J]. Chinese Journal of Antituberculosis, 2023, 45(7): 658-668.
|
[2] |
Peng Jiangli, Chen Jie, Chen Yonggang, Wang Lu, Li Na, Luo Ji, Han Yi, Yu Mingli, Zhu Jiangchun.
SLC22A12 gene polymorphism study on susceptibility to hyperuricemia induced by pyrazinamide
[J]. Chinese Journal of Antituberculosis, 2023, 45(2): 151-158.
|
[3] |
Yu Meiling, Zhang Chenchen, Wei Wenjing, Zhao Yuchuan, Zhuo Wenji, Zheng Lei.
Study on high-concentration p-aminosalicylic acid resistant Mycobacterium tuberculosis induced in vitro and the mutation sites
[J]. Chinese Journal of Antituberculosis, 2023, 45(1): 60-66.
|
[4] |
Wei Shuzhen, Zhao Yong, Lin Jian, Lin Shufang, Dai Zhisong.
Analysis of genotype characteristics and drug resistance of Mycobacterium tuberculosis isolates in Fujian Province from 2017 to 2019
[J]. Chinese Journal of Antituberculosis, 2023, 45(1): 73-78.
|
[5] |
WANG Ning, ZHENG Lu-yao, MENG Xiu-juan, LIU Hai-ting, DING Yang-ming, YAO Rong, GUO Shao-chen, LU Yu.
Distribution characteristics of N-acetyltransferase-2 genotypes and comparison methods of different genotyping in Chinese population
[J]. Chinese Journal of Antituberculosis, 2022, 44(6): 625-634.
|
[6] |
TIAN Li, ZHOU Wei, HUANG Xing, WU Xian-wei, ZHANG Hui-yong, LU Zhen-hui, ZHANG Shao-yan.
Analysis of gene mutation characteristics of isoniazid-resistant Mycobacterium tuberculosis in China
[J]. Chinese Journal of Antituberculosis, 2022, 44(4): 354-361.
|
[7] |
Wu Kunyang, Lu Yewei, Zhang Mingwu, Zhu Yelei, Li Xiangchen, Pan Junhang, Wang Xiaomeng, Wang Wei, Jiang Minmin, Peng Xiaojun, Wang Weixin, Gao Junshun, Liu Zhengwei.
Analysis on characteristic of drug resistance-associated gene mutations and the correlation with genotypes among Mycobacterium tuberculosis isolates in Zhejiang Province
[J]. Chinese Journal of Antituberculosis, 2022, 44(11): 1126-1134.
|
[8] |
MA Ting-ting, REN Fei, MA Jin-bao, YANG Han.
Resistance of prothionamided and sodium aminosalicylate among isoniazid resistant pulmonary tuberculosis patients
[J]. Chinese Journal of Antituberculosis, 2021, 43(9): 961-964.
|
[9] |
LUO Dan, QIN Hui-fang, YE Jing, ZHAO Jin-ming, QIN Yi-xiang, LAN Ru-shu.
Analysis on gene mutation characteristics of drug resistant Mycobacterium tuberculosis and its correlation with genotypes in Guangxi
[J]. Chinese Journal of Antituberculosis, 2021, 43(6): 596-601.
|
[10] |
Beijing Chest Hospital, Capital Medical University, Clinical Trial Branch of the Chinese Antituberculosis Association, Editorial Board of Chinese Journal of Antituberculosis .
Guideline for clinical application of cycloserine in the treatment of tuberculosis
[J]. Chinese Journal of Antituberculosis, 2020, 42(6): 533-540.
|
[11] |
HONG Chuang-yue, YANG Ting-ting, LI Jin-li, LI Shuang-jun, WU Li-kai, YANG Zheng, TAN Wei-guo.
Analysis of characteristic of resistant gene mutations among multidrug-resistant Mycobacterium tuberculosis in Shenzhen
[J]. Chinese Journal of Antituberculosis, 2020, 42(6): 583-589.
|
[12] |
ZHAO Ben-nan, LIU Da-feng, LIU Ya-ling, YANG Ming, LAN Li-juan, DU Qing.
Clinical analysis of hypothyroidism after anti-tuberculosis treatment in patients with multidrug-resistant tuberculosis
[J]. Chinese Journal of Antituberculosis, 2020, 42(5): 465-471.
|
[13] |
Xiao-jun LIU,Feng-hua YU,Yun-fang YU,L-yu JI,Pan ZHOU,Yan-lin ZHAO.
MIRU-VNTR genotyping and clustering of Mycobacterium tuberculosis isolates in Yichang
[J]. Chinese Journal of Antituberculosis, 2019, 41(3): 308-314.
|
[14] |
Ying PENG,Lu TANG,Xin-fa PEI,Xue-ZHi ZHANG,Bai-feng LIN,Li CHEN,Yan-ling YU,Fa-bin LI.
Genotypic and transmission characteristics of Mycobacterium tuberculosis in Wuchang City, Heilongjiang Province
[J]. Chinese Journal of Antituberculosis, 2019, 41(3): 315-321.
|
[15] |
Tong XIE,Chun-hua WANG,Hui ZHAO,Han-fang JU,Cheng MU,Zhi-rui WANG,Rui SUN.
Genotypic analysis of Mycobacterium tuberculosis among prison population in Tianjin, China
[J]. Chinese Journal of Antituberculosis, 2019, 41(3): 361-363.
|